The appointment coincides with the 20th anniversary of RevitaLash, as the company pushes toward a $20 million cumulative contribution milestone for breast cancer initiatives. Since its founding in 2006, the brand has evolved from a personal project into a global enterprise sold in over 70 countries, donating more than $14 million to research and charitable causes along the way. In 2026 alone, the company distributed over 13,000 products to nonprofit organizations.

Dr. Brinkenhoff will be formally recognized at the Spirit of Life Gala, scheduled for January 14, 2027, at The Beverly Hills Hotel. Beyond corporate donations, the partnership includes the Gayle Brinkenhoff Excellence in Cancer Research Award and an annual symposium designed to accelerate clinical progress in treating complex breast cancers. Kristin J. Bertell, chief philanthropy officer at City of Hope, noted that Brinkenhoff’s background as an ophthalmologist provides a unique, human-centered perspective to the organization’s research efforts. Industry partners are invited to join the campaign through sponsorships and direct contributions to support the institution's ongoing work in oncology.